A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Long‐ QT syndrome ( LQTS ) is an arrhythmogenic disorder characterised by prolongation of the QT interval in the electrocardiogram, which can lead to sudden cardiac death. Pharmacological treatments are far from optimal for congenital forms of LQTS , while the acquired form, often triggered by drugs that (sometimes inadvertently) target the cardiac hERG channel, is still a challenge in drug development because of cardiotoxicity. Current experimental models in vitro fall short in predicting proarrhythmic properties of new drugs in humans. Here, we leveraged a series of isogenically matched, diseased and genetically engineered, human induced pluripotent stem cell‐derived cardiomyocytes (hi PSC ‐ CM s) from patients to test a novel hERG allosteric modulator for treating congenital LQTS , drug‐induced LQTS or a combination of the two. By slowing I K r deactivation and positively shifting I K r inactivation, the small molecule LUF 7346 effectively rescued all of these conditions, demonstrating in a human system that allosteric modulation of hERG may be useful as an approach to treat inherited and drug‐induced LQTS . Furthermore, our study provides experimental support of the value of isogenic pairs of patient hi PSC ‐ CM s as platforms for testing drug sensitivities and performing safety pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Self-citationWang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3545 · Cited by 837 · cited 3×
“The generation of isogenic controls by gene repair has already proven successful in identifying causative mutations, especially in the case of mild phenotypes (Bellin et al, 2013; Wang et al, 2014a).”
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389 · cited 1×
“In contrast with findings described by others (Matsa et al, 2011), hERG modulation by LUF7346 completely reversed the severe effects of the potassium channel blocker AST in LQT2N996I hiPSC-CMs, confirming the efficacy of LUF7346 compared to other molecules reported so far in the literature.”
Cited by
Sala, L., van Meer, B. J., Tertoolen, L. G. J., Bakkers, J., Bellin, M., Davis, R. P., Denning, C., Dieben, M. A. E., Eschenhagen, T., Giacomelli, E., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312067 · Cited by 416
“Methods and Results: MUSCLEMOTION allowed rapid and easy measurement of movement from highspeed movies in (1) 1-dimensional in vitro models, such as isolated adult and human pluripotent stem cellderived cardiomyocytes; (2) 2-dimensional in vitro models, such as beating cardiomyocyte monolayers or small clusters of hum…”
InfluentialSelf-citationGiacomelli, E., Bellin, M., Sala, L., van Meer, B. J., Tertoolen, L. G. J., Orlova, V. V., & Mummery, C. L. (2017) · Development · doi:10.1242/dev.143438 · Cited by 279
Self-citationProtze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
De Masi, C., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. (2020) · Human Genomics · doi:10.1186/s40246-020-00276-2 · Cited by 91
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
Sala, L., Gnecchi, M., & Schwartz, P. J. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.1.1 · Cited by 54
Self-citation
Metadata
- Authors
- Sala, L., Yu, Z., Ward‐van Oostwaard, D., van Veldhoven, J. P., Moretti, A., Laugwitz, K., Mummery, C. L., IJzerman, A. P., & Bellin, M.
- Venue
- EMBO Molecular Medicine
- Published
- 2016-07-28
- Volume
- 8
- Issue
- 9
- Pages
- 1065-1081
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2501001405
- Cited by
- 87
- References
- 3
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. https://app.cochat.ai/papers/10.15252/emmm.201606260
- The paper
- Sala, L., Yu, Z., Ward‐van Oostwaard, D., van Veldhoven, J. P., Moretti, A., Laugwitz, K., Mummery, C. L., IJzerman, A. P., & Bellin, M. (2016). A new hERG allosteric modulator rescues genetic and drug‐induced long‐ QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201606260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.